Fig. 6.
(A) Patient survival over time. (B) Patient survival over time in patients who received second-line or greater therapy. P values from log-rank test. Survival indicates time from first dose of study drug to date of death. [106]
(A) Patient survival over time. (B) Patient survival over time in patients who received second-line or greater therapy. P values from log-rank test. Survival indicates time from first dose of study drug to date of death. [106]